Answers are grounded in this paper and cite their sources.
Vitiligo is an acquired autoimmune pigmentary disorder characterized by selective melanocyte loss. While oxidative stress and immune dysregulation are well-established contributors, the upstream mechanisms that initiate melanocyte vulnerability remain incompletely understood. In this narrative review, we propose impaired mitochondrial quality control (MQC) as an emerging mechanistic hypothesis that may link key pathogenic events in vitiligo. MQC, encompassing mitophagy, mitochondrial dynamics, and biogenesis, is essential for maintaining melanocyte bioenergetics, redox homeostasis, and survival under ultraviolet (UV) and environmental stress. We summarize current evidence suggesting that abnormalities in PINK1/Parkin-mediated mitophagy, dysregulated fission/fusion dynamics, and impaired PGC-1α/NRF1-driven biogenesis are associated with the accumulation of dysfunctional mitochondria in vitiligo melanocytes. These mitochondrial perturbations may contribute to metabolic adaptation, augmented reactive oxygen species (ROS) production, cytosolic mtDNA release, and downstream innate and adaptive immune activation reported in vitiligo, subsequently driving the characteristic features of vitiligo lesions. However, whether MQC abnormalities represent a primary pathogenic driver, a secondary consequence of chronic oxidative stress, or a bidirectional relationship remains to be established. Thus, we critically discuss the perspective that phytochemicals may act as potential modulators of MQC. Unlike general antioxidants, specific plant-derived compounds such as quercetin, sulforaphane, epigallocatechin gallate (EGCG), and ginkgolides have been reported in preclinical models to modulate mitophagy, rebalance mitochondrial dynamics, and promote biogenesis, thereby targeting mitochondrial homeostasis rather than only its downstream consequences. By repositioning impaired MQC as an attractive, yet to be validated, hypothesis that may offer new insight into vitiligo pathogenesis, this review provides a framework for future investigation and highlights phytochemical-mediated restoration of mitochondrial homeostasis as a potential therapeutic avenue that warrants further experimental validation.
No takes yet. Share an insight, caveat, or question.
Banda-Lesole et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: